Thank you to all attendees, speakers and sponsors. Speakers’ presentations and videos recorded at the meeting are available at the Programme Page. Click on each title to download the related presentation.
The conference is organized around the major theme of inhibitors. One of the most important issues in hemophilia treatment at this stage is the development of inhibitors against FVIII, which is present in almost 30-35% of the children treated with the actual products.
Flora Peyvandi and Pier Mannuccio Mannucci
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center,
University of Milan, Department of Medical and Surgical Physiopathology
IRCCS Fondazione Ca’ Granda Ospedale Maggiore Policlinico, Milan, ITALY